SMAD7 and cancer: In addition, most of the functional studies of SMAD7 that validated its TGFβ-inhibitory role in cancer have been carried out with ectopic overexpression of the gene33, 39, 40, 41, 42, thus not necessarily reflecting what actually occurs in cancer cells after TGFβ treatment.